Dale Yoo, MD
Clinical Cardiac Electrophysiology · McKinney, TXNPI 1780799015
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (37.9%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Abbott accounts for 64.1% of it on its own, with 54 other manufacturers making up the rest. Among clinical cardiac electrophysiology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,634 payments — averaging $357.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$375K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$119K
- Itamar Medical Inc$21K
- Sanofi-aventis U.S. LLC$14K
- Pfizer$10K
- Atricure, Inc.$10K
- plus $37K from 49 others
Across 30 payments — averaging $4005.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$83K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$32K
- Impulse Dynamics (USA) Inc.$4K
- Boston Scientific$1K
What the payments were for
- Consulting fees$221,63538%
- Speaking & faculty fees$127,43422%
- Travel & lodging$166,62028%
- Food & beverage$69,09412%
- Education$440%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LifeVest$114,254
- ENSITE$54,599
- AVEIR$47,924
- ADVISOR$40,539
- AMPLATZER AMULET$37,552
- Assurity Pacemaker$35,270
- ACCENT$18,387
- WatchPATONE$15,987
- Confirm Rx$14,592
- EnSite Precision Cardiac Mapping System$13,729
- ENSITE PRECISION$13,714
- Merlin Connectivity and Remote$12,205
- ALLURE QUADRA$11,087
- ELIQUIS$9,441
- Quadra Assura CRT Defibrillator$9,167
- VERQUVO$8,540
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$8,243
- Fortify Assura, Ellipse ICD$7,500
- ECM Patch,Pouch$7,152
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$6,106
How this compares
$584,827 in reported general payments places this provider in the 95th percentile of 233 clinical cardiac electrophysiology providers in Texas.
See all clinical cardiac electrophysiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyndamaxTafamidis | 20 | $448,854 |
| EliquisApixaban | 141 | $161,012 |
| EntrestoSacubitril/Valsartan | 108 | $131,613 |
| XareltoRivaroxaban | 19 | $21,738 |
| MultaqDronedarone Hcl | 18 | $19,693 |
| VerquvoVericiguat | 20 | $18,342 |
| FarxigaDapagliflozin Propanediol | 19 | $16,653 |
| JardianceEmpagliflozin | 14 | $12,573 |
| Propafenone Hcl ErPropafenone Hcl | 31 | $8,078 |
| Flecainide Acetate | 169 | $7,240 |
| Metoprolol Succinate | 243 | $4,494 |
| Midodrine Hcl | 40 | $3,804 |
| SotalolSotalol Hcl | 157 | $3,534 |
| Amiodarone Hcl | 99 | $2,650 |
| Colchicine | 20 | $1,513 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerVyndamax, Eliquis | $9,965 | $609,866161 claims |
| NovartisEntresto | $340 | $131,613108 claims |
| Johnson & JohnsonXarelto | $142 | $21,73819 claims |
| Sanofi-aventis U.S. LLCMultaq | $13,775 | $19,69318 claims |
| MerckVerquvo | $5,117 | $18,34220 claims |
| AstraZenecaFarxiga | $23 | $16,65319 claims |
| Boehringer IngelheimJardiance | $200 | $12,57314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 233 clinical cardiac electrophysiology providers in Texas.
Other clinical cardiac electrophysiology in McKinney
- Justin ArunthamakunMcKinney$79K
- Michael DelaughterBedford$1.6M
- Andrea NataleAustin$1.3M
- Jason ZagrodzkyAustin$961K
- Amin Al-AhmadAustin$771K
- Rodney HortonAustin$553K
- Jose Cuellar SilvaWebster$502K
- Miguel ValderrabanoHouston$461K
- Theodore TakataFort Worth$396K
- Muhie Dean SabayonGalveston$361K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.